WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H574992
CAS#: 52212-02-9
Description: Pipecuronium bromide is a bisquaternary aminosteroid muscle relaxant which acts at the nicotinic acetylcholine receptor of the neuromuscular junction. Pipecuronium is a non-depolarizing neuromuscular blocking agent.
Hodoodo Cat#: H574992
Name: Pipecuronium bromide
CAS#: 52212-02-9
Chemical Formula: C35H62Br2N4O4
Exact Mass: 760.31
Molecular Weight: 762.713
Elemental Analysis: C, 55.12; H, 8.19; Br, 20.95; N, 7.35; O, 8.39
Synonym: Arduan; Pipecuronium bromide; RGH1106; RGH-1106; RGH 1106
IUPAC/Chemical Name: 4,4'-((2beta,3alpha,5alpha,16beta,17beta)-3,17-Bis(acetoxy)androstane-2,16-diyl)bis(1,1-dimethylpiperazinium) dibromide
InChi Key: TXWBOBJCRVVBJF-YTGGZNJNSA-L
InChi Code: InChI=1S/C35H62N4O4.2BrH/c1-24(40)42-32-21-26-9-10-27-28(35(26,4)23-31(32)37-15-19-39(7,8)20-16-37)11-12-34(3)29(27)22-30(33(34)43-25(2)41)36-13-17-38(5,6)18-14-36;;/h26-33H,9-23H2,1-8H3;2*1H/q+2;;/p-2/t26-,27+,28-,29-,30-,31-,32-,33-,34-,35-;;/m0../s1
SMILES Code: [Br-].[Br-].CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(=O)C)N5CC[N+](C)(C)CC5)[C@@]2(C)C[C@@H]1N6CC[N+](C)(C)CC6
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
| Biological target: | |
| In vitro activity: | |
| In vivo activity: |
The following data is based on the product molecular weight 762.71 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
| Formulation protocol: | |
| In vitro protocol: | |
| In vivo protocol: |
1. Stanley JC, Mirakhur RK, Bell PF, Sharpe TD, Clarke RS. Neuromuscular effects of pipecuronium bromide. Eur J Anaesthesiol. 1991 Mar;8(2):151-6. PMID: 1651856.
